Phase I

This is the first blog entry in a two-part series on journal selection. By Ryan McGuire,Senior Research Analyst Evaluating the medical journal landscape is the first step toward making sure manuscripts find their way to the appropriate home. In fact,...

Clinical development outsourcing budgets have steadily risen since 2008, but Phase II outsourcing has grown at a faster rate than any other phase, according to our recent clinical development study. Patient recruitment, complex setup requirements, and the need...

New research finds pharma pricing teams gaining strategic importance and greater resources. The average cost for pricing activities supporting innovative drugs is $974,000 from Phase I through a brand’s second year on the market, according to research in our...

The size of the average clinical research operations department has more than doubled since 2008. According to our data, this growth trend spans all phases of development and appears likely to continue as companies aim to invest in clinical trial staffing to get...

Five years ago, many companies waited to set most of their market access strategy until Phase III - and in some cases, after registration and launch. Like other departments, market access teams have undergone a swift evolution in recent years as pipeline progress...

Usage Remains Limited Due to Learning Curve and Regulatory Concern Adaptive clinical design can lead to significant time savings when implemented successfully, according to our current clinical operations study. However, two major ingredients are still needed...